Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06405256
Status:
RECRUITING
Last Update Posted:
2024-05-08
First Post:
2024-05-04
Brief Title:
Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Study Overview
Official Title:
Displacement and Deformation Analysis of Adaptive Radiotherapy Based on MR-Linac for Large Brain Metastases
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is an ambispective cohort study to evaluate the displacement and deformation of large brain metastases BM treated with magnetic resonance imaging-guided adaptive radiotherapy MRIgART
Detailed Description:
All patients had a pathologically confirmed malignant cancer and were diagnosed with brain metastases BM by enhanced magnetic resonance imaging MRI with BM volume of 2cm and above All patients received Unity MR-linac adaptive radiotherapy Gross tumor volume GTV and organs at risk OARs were re-delineated for every image set and analyzed for displacement and deformation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None